PATENT CLAIM ANALYSIS

Application Number: 15756014
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "329000"]

Abstract:
The present invention provides using a substituted 1-arylalkyl-4-acylaminopiperidine compound of Formula I: to treat various clinical conditions including, but not limited to, hemorrhagic shock, nicotine withdrawal symptoms, gastrointestinal side effects of opioids, cancer therapy, epithelial wounds, herpes zoster infection, or opioid-induced pruritus. In compound of Formula I, R 1  is C 1-10  alkyl, C 1-10  haloalkyl, optionally substituted aryl, or optionally substituted heteroaryl; R 2  is C 1-6  alkylene; Y is optionally substituted aryl, optionally substituted heteroaryl, or a moiety of the formula —C(═O)—X 1 , wherein X 1  is —OR 3  or —NR 4 R 5 , where each of R 3 , R 4  and R 5  is H or C 1-10  alkyl.

Claim (Index 4):
The method of  claim 1 , wherein Y is selected from the group consisting of phenyl, thiophen-2-yl, and a moiety of the formula \u2014C(\u2550O)\u2014OR 3 , where R 3  is C 1-10  alkyl.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 88.0
- Lexical Diversity: 1.76923
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14834185', '13017860', '12828800', '14047469', '13014314']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7737192714878862
- 35 USC 102 Novelty (BERT): 0.5041692258091353
- Combined Prediction Score: 0.7467642669200112
- Mean Citation Score: 238.6757
- Max Citation Score: 265.4231
- Similarity Product: 212.33349972246884

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test